A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
Clinical trial NCT06624228 · COMPLETED
Trial details
- NCT number
- NCT06624228
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-02-06
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.